Health insurance to cover new drugs with less economic effectiveness

The price of a new drug, which lacks an economic effectiveness, despite its clinical efficacy, will get listed for insurance coverage, provided that a drug maker would accept a lower weighed average price, the Health Insurance Review and Assessment Service said on August 6.

Under the revised health insurance law, a pharmaceutical company will be able to renegotiate with the National Health ...